IMPRA VASCULAR GRAFT F7006TWS

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor,foreign,health pr report with the FDA on 2016-09-09 for IMPRA VASCULAR GRAFT F7006TWS manufactured by Bard Peripheral Vascular, Inc..

Event Text Entries

[54406055] No medical records or medical images have been made available to the manufacturer. As the lot number for the device was provided, a review of the device history records is currently being performed. The device has been returned to the manufacturer for evaluation. The investigation of the reported event is currently underway. The information provided by bard represents all of the known information at this time. Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
Patient Sequence No: 1, Text Type: N, H10


[54406056] It was reported that during preparation, the beading from the vascular graft was allegedly unraveled. It was further reported that the vascular graft was allegedly torn. There was no reported patient involvement.
Patient Sequence No: 1, Text Type: D, B5


[58760537] Manufacturing review: a manufacturing review was conducted, the lot met all release criteria. Visual inspection: the sample was bloody. As the reported event was reported to occur during preparation, the blood most likely transferred to the device. The segments returned could not be measured for length due to returned condition. The first segment is the smaller of the two returned segments. The beading is unraveled from the segments and is torn along the beading track. There were no suture holes identified along the length of the returned segment. The second segment consist of what appears to be the remainder of the graft. The beading is unraveled along most of the length of the segment. The graft segment is torn in a spiral manner along the beading track. Remnants of eptfe can be identified on the removed beading. There were no suture holes identified along the length of the returned segment. Functional/performance evaluation: functional testing is not preformed for this type of failure. Medical records review: medical records were not provided; therefore, a review could not be performed. Image/photo review: one digital photo was reviewed. A graft product can be identified within packaging. One end of the graft appears to be torn spirally along the beading track. It can not be determined if the beading is removed from the graft. Based on the image the investigation can be confirmed for torn material. Conclusion: the device was returned for evaluation. One photo was also provided for review. The investigation is confirmed for torn material, as the returned device exhibited spiral tears along the length of the beading track. Labeling review: the current ifu states: precautions: when removing the external spiral support (beading) of the graft, the beading must be removed slowly and at a 90? Angle to the graft. Rapid unwinding and /or removal at less than a 90? Angle may result in graft damage. Do not use surgical blades or sharp, pointed instruments to remove the beading as this may damage the graft wall. If damage occurs, that segment of the graft should not be used. (b)(4). The information provided by bard represents all of the known information at this time. Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
Patient Sequence No: 1, Text Type: N, H10


[58760538] It was reported that during preparation, upon removal of the beading from the vascular graft, the graft allegedly tore. There was no patient contact.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2020394-2016-00863
MDR Report Key5941086
Report SourceDISTRIBUTOR,FOREIGN,HEALTH PR
Date Received2016-09-09
Date of Report2016-08-17
Date of Event2016-08-09
Date Mfgr Received2016-10-18
Device Manufacturer Date2016-01-27
Date Added to Maude2016-09-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJUDITH LUDWIG
Manufacturer Street1625 W 3RD ST.
Manufacturer CityTEMPE AZ 85281
Manufacturer CountryUS
Manufacturer Postal85281
Manufacturer Phone4803032689
Manufacturer G1BARD PERIPHERAL VASCULAR, INC.
Manufacturer Street1625 W 3RD ST.
Manufacturer CityTEMPE AZ 85281
Manufacturer CountryUS
Manufacturer Postal Code85281
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameIMPRA VASCULAR GRAFT
Generic NameVASCULAR GRAFT
Product CodeDYF
Date Received2016-09-09
Returned To Mfg2016-09-06
Catalog NumberF7006TWS
Lot NumberVTAN0522
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerBARD PERIPHERAL VASCULAR, INC.
Manufacturer Address1625 W 3RD ST. TEMPE AZ 85281 US 85281


Patients

Patient NumberTreatmentOutcomeDate
10 2016-09-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.